DuPont de Nemours, Inc. (NYSE:DD) Q3 2024 Earnings Preview

• The consensus price target for DuPont de Nemours, Inc. (NYSE: DD) has experienced significant fluctuations, indicating a shift in analyst sentiment.
• Despite a recent drop in the price target, Deutsche Bank analyst David Begleiter has set a higher target of $90, showing confidence in DuPont's financial performance.
• DuPont is expected to release its third-quarter 2025 earnings soon, with forecasts suggesting earnings of $1.13 per share and revenue of approximately $3.1 billion.

DuPont de Nemours, Inc. (NYSE: DD) is a key player in the technology-based materials and solutions industry, with operations spanning the globe. The company is divided into three main segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. These segments serve a variety of industries, providing essential products and solutions. DuPont competes with other major companies in the sector, striving to maintain its position through innovation and strategic growth.

The consensus price target for DuPont has seen significant fluctuations recently. Last month, the target was $47, a sharp decline from $79.6 in the previous quarter. This suggests a shift in analyst sentiment, possibly due to recent developments or market conditions affecting DuPont's business segments. Despite this, Deutsche Bank analyst David Begleiter has set a higher price target of $90, indicating confidence in DuPont's financial performance.

Comparing the last quarter's average price target of $79.6 to last year's $82.5 shows a slight decrease, suggesting a relatively stable outlook over the longer term. However, the recent drop to $47 indicates more immediate concerns or adjustments. DuPont is expected to release its third-quarter 2025 earnings results soon, with analysts forecasting earnings of $1.13 per share and revenue of approximately $3.1 billion. The company's strong track record of surpassing earnings expectations may influence future price targets.

The substantial drop from $82.5 last year to $47 last month highlights a significant change in analyst expectations over the past year. This could be due to various factors such as changes in market dynamics, company performance, or broader economic conditions. DuPont's upcoming earnings report will be closely watched, as it may provide insights into the company's current standing and future prospects.

Market conditions, company performance, and sector trends all play a role in influencing price target changes. Fluctuations in the global economy, supply chain disruptions, or changes in demand for DuPont's products could impact analyst expectations. Recent earnings reports, strategic decisions, or changes in leadership might also have influenced the consensus price target. As DuPont prepares to release its third-quarter earnings, investors will be keen to see if the company can continue its trend of surpassing expectations.

In the recent market analysis, several companies have emerged as top losers, experiencing significant price movements and changes in their market performance. This analysis consolidates information from multiple sources to provide a comprehensive overview of these companies, focusing on DuPont de Nemours, Inc. (NYSE:DD), NOMADAR Corp. Class A Common Stock (NASDAQ:NOMA), uniQure N.V. (NASDAQ:QURE), TScan Therapeutics, Inc. (NASDAQ:TCRX), and ZOOZ Strategy Ltd. (NASDAQ:ZOOZ).

DuPont de Nemours, Inc. (DD) has seen a dramatic decrease in its stock price, dropping by 47.32% to $34.33, significantly below its yearly high of $87.8. Despite its extensive operations across various sectors, the company's recent price movement could be attributed to market reactions to external factors or possibly internal developments. As highlighted by the company's recent collaboration with Hohenstein, DuPont is launching innovative testing protocols for body armor, aiming to enhance performance and user experience.

NOMADAR Corp. Class A Common Stock (NOMA), a newcomer in the sport technology business, has faced a steep decline, with its stock price falling by 48.57% to $10.80. This is a significant drop from its year high of $57.7. The company, operating at the intersection of sports, tourism, technology, and health, has begun trading on the Nasdaq Capital Market, marking a significant milestone as it enters the public market.

uniQure N.V. (QURE), a gene therapy company, experienced a 51.35% decrease in its stock price, now at $32.93. The decline follows feedback from the U.S. Food and Drug Administration (FDA) on its investigational gene therapy for Huntington's disease, impacting investor confidence. Despite the promising nature of its research and development, the stock has significantly underperformed in the market.

TScan Therapeutics, Inc. (TCRX) saw its stock price decrease by 37.37% to $1.21. The company's market performance reflects the volatile nature of biotechnology investments. TScan has reached an agreement with the FDA on the pivotal study design for TSC-101 and has enacted a 30% workforce reduction to prioritize clinical development efforts, extending its cash runway into the second half of 2027.

ZOOZ Strategy Ltd. (ZOOZ) witnessed a 44.06% decline in its stock price to $0.78. Despite the growing global emphasis on electric vehicles, ZOOZ's market performance has been less than favorable. The company has announced a $50 million share repurchase program, reflecting confidence in its financial health and commitment to enhancing shareholder value.

These significant price movements underscore the volatile nature of the stock market, influenced by a myriad of factors including company developments, market sentiment, and broader economic conditions. Investors and stakeholders closely monitor these companies, looking for signs of recovery or further decline in their market performance.

• The consensus target price for DuPont de Nemours, Inc. (NYSE:DD) has slightly increased from $86 to $87 in the short term, indicating a modest positive sentiment among analysts.
• Over the past year, the average target price has decreased from $91 to $87, reflecting potential concerns over market conditions or company performance.
• Despite a yearly decrease in the target price, analyst David Begleiter from Deutsche Bank has a more optimistic view with a price target of $90.

DuPont de Nemours, Inc. (NYSE:DD) is a leading global provider of technology-based materials and solutions, operating through three main segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. These segments serve a diverse range of industries, including advanced printing, semiconductor fabrication, transportation, renewable energy, and water purification. With its headquarters in Wilmington, Delaware, DuPont, formerly known as DowDuPont Inc., underwent a name change in June 2019.

The consensus target price for DuPont has experienced fluctuations over various time frames. Last month, the average price target was $87, a slight increase from $86 last quarter. This indicates a modest positive sentiment among analysts in the short term. The quarterly change from $86 to $87 suggests a stable outlook with a slight upward adjustment in expectations.

However, when examining the yearly change, the average target price has decreased from $91 to $87. This decline may reflect changes in market conditions, company performance, or broader economic factors affecting the industry. Despite this, analyst David Begleiter from Deutsche Bank has set a price target of $90 for DuPont, indicating a more optimistic view.

DuPont is anticipated to experience earnings growth in its upcoming report. However, it is suggested that the company may not have the optimal combination of factors necessary for an earnings beat. This could be a reason for the cautious approach seen in the yearly target price decrease. Investors should consider these trends along with other factors such as recent company performance, industry developments, and broader economic conditions when evaluating DuPont's stock.

• The consensus price target for DuPont de Nemours, Inc. (NYSE: DD) has decreased from $96.9 to $90, reflecting a 7.1% decline.
• Market conditions, strategic initiatives, and regulatory changes are key factors influencing analysts' price targets and expectations for DuPont.
• Despite potential earnings growth, DuPont may not have the ideal combination of factors for an earnings beat according to Deutsche Bank analyst David Begleiter.

DuPont de Nemours, Inc. (NYSE: DD) is a global leader in the chemical industry, known for its innovative solutions in sectors like electronics, transportation, and water protection. The company has a rich history of providing high-performance materials and technologies. DuPont faces competition from other major players in the chemical industry, such as BASF and Dow Inc.

Over the past year, analysts have adjusted their expectations for DuPont's stock. The consensus price target has decreased from $96.9 to $90, reflecting a 7.1% decline. This change may be influenced by various factors, including recent earnings reports. DuPont is expected to show earnings growth in its upcoming report, but it may not have the ideal combination of factors for an earnings beat, as noted by analyst David Begleiter from Deutsche Bank.

Market conditions also play a significant role in shaping analysts' price targets. Economic factors and industry trends, such as demand for DuPont's products in electronics and transportation, can impact expectations. Changes in these sectors could have contributed to the steady price target of $90 over the last quarter and month.

Strategic initiatives by DuPont, including mergers, acquisitions, and a focus on innovation and sustainability, might have influenced analysts' outlook. These moves can affect the company's long-term growth prospects and, consequently, its stock price target. Investors should keep an eye on any strategic developments that DuPont undertakes.

Regulatory changes are another factor that can impact analysts' assessments. As DuPont operates in various industries, any changes in regulations affecting these sectors could influence the company's future performance. Investors should consider these regulatory factors when evaluating DuPont's stock, alongside company performance and broader economic conditions.

• The consensus price target for DuPont de Nemours, Inc. (NYSE: DD) has decreased from $96.9 to $90, reflecting a 7.1% decline.
• Market conditions, strategic initiatives, and regulatory changes are key factors influencing analysts' price targets and expectations for DuPont.
• Despite potential earnings growth, DuPont may not have the ideal combination of factors for an earnings beat according to Deutsche Bank analyst David Begleiter.

DuPont de Nemours, Inc. (NYSE: DD) is a global leader in the chemical industry, known for its innovative solutions in sectors like electronics, transportation, and water protection. The company has a rich history of providing high-performance materials and technologies. DuPont faces competition from other major players in the chemical industry, such as BASF and Dow Inc.

Over the past year, analysts have adjusted their expectations for DuPont's stock. The consensus price target has decreased from $96.9 to $90, reflecting a 7.1% decline. This change may be influenced by various factors, including recent earnings reports. DuPont is expected to show earnings growth in its upcoming report, but it may not have the ideal combination of factors for an earnings beat, as noted by analyst David Begleiter from Deutsche Bank.

Market conditions also play a significant role in shaping analysts' price targets. Economic factors and industry trends, such as demand for DuPont's products in electronics and transportation, can impact expectations. Changes in these sectors could have contributed to the steady price target of $90 over the last quarter and month.

Strategic initiatives by DuPont, including mergers, acquisitions, and a focus on innovation and sustainability, might have influenced analysts' outlook. These moves can affect the company's long-term growth prospects and, consequently, its stock price target. Investors should keep an eye on any strategic developments that DuPont undertakes.

Regulatory changes are another factor that can impact analysts' assessments. As DuPont operates in various industries, any changes in regulations affecting these sectors could influence the company's future performance. Investors should consider these regulatory factors when evaluating DuPont's stock, alongside company performance and broader economic conditions.

DuPont (NYSE:DD) delivered better-than-expected fourth-quarter earnings, fueled by robust demand in electronics and resurgent growth in water and healthcare markets. The upbeat results, coupled with an optimistic 2025 forecast, sent the stock up 8% intra-day today.

For Q4, the chemical giant reported adjusted earnings per share of $1.13, surpassing analyst expectations of $0.99. Revenue came in at $3.09 billion, slightly above estimates of $3.08 billion, reflecting a 7% year-over-year increase in both net and organic sales.

The strong performance was driven by an 8% volume increase, particularly in electronics markets, while a 1% price decline provided a slight offset. Healthcare saw renewed strength in medical packaging and biopharma, while water market growth accelerated, signaling broad-based recovery across key sectors.

Looking ahead, DuPont provided an optimistic outlook for 2025. The company expects Q1 earnings per share of $0.95, slightly ahead of analyst forecasts of $0.93, with revenue projected at $3.025 billion. Full-year 2025 guidance includes EPS between $4.30 and $4.40 and revenue in the range of $12.8 billion to $12.9 billion.

DuPont de Nemours, Inc. (NYSE:DD) is a prominent player in the chemical industry, known for its diversified product offerings. The company operates within the Zacks Chemical - Diversified industry, competing with other major chemical firms. DuPont's recent financial performance has been noteworthy, reflecting its strong market position and ability to adapt to changing industry dynamics.

On February 11, 2025, DuPont reported earnings per share (EPS) of $1.13, surpassing the estimated $0.98. This represents a significant earnings surprise of 15.31%, as highlighted by Zacks. Compared to the previous year's EPS of $0.87, this marks a notable increase, showcasing the company's growth trajectory. DuPont has consistently exceeded consensus EPS estimates over the past four quarters, demonstrating its ability to outperform market expectations.

In terms of revenue, DuPont achieved approximately $3.09 billion for the quarter ending December 2024, slightly above the estimated $3.07 billion. This 0.82% revenue surprise, as noted by Zacks, indicates the company's ability to generate higher-than-expected sales. Compared to the $2.9 billion reported in the same quarter the previous year, DuPont's revenue growth highlights its strong market presence and effective business strategies.

DuPont's stock experienced a significant increase following the release of its strong earnings report. The positive performance is largely attributed to a recovery in semiconductor demand, driven by advancements in AI technology and stronger market demand in China. This recovery has bolstered DuPont's financial results, contributing to its impressive earnings and revenue figures.

DuPont's financial metrics further underscore its solid performance. With a price-to-earnings (P/E) ratio of approximately 39.89, investors are willing to pay a premium for each dollar of earnings. The company's price-to-sales ratio of about 2.61 and enterprise value to sales ratio of around 3.07 reflect its valuation compared to sales. Additionally, DuPont's low debt-to-equity ratio of 0.30 and current ratio of approximately 2.28 indicate good financial health, with ample current assets to cover liabilities.